# Mepolizumab and Physical Activity in Severe Asthma

> **NCT05404763** · — · ACTIVE_NOT_RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 62 (actual)

## Conditions studied

- Asthma
- Asthma; Eosinophilic

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05404763
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-02-02
- **Primary completion:** 2026-08-02
- **Final completion:** 2026-08-02
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2026-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05404763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05404763, "Mepolizumab and Physical Activity in Severe Asthma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05404763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*